Internal Medicine Doctors in Coppell, TX Accepting Medicare

5 Internal Medicine doctors found. Showing 1 - 5

Divyaswapnika Javvaji, M.D Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 S Denton Tap Rd Ste 275, Coppell, TX 75019 Phone: 972-393-1699    Fax: 972-393-1702

Farhana Kazi, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 215 S Denton Tap Rd Ste 225, Coppell, TX 75019 Phone: 469-293-2067    Fax: 469-293-2083

Mr. Monsur Ali, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 546 E Sandy Lake Rd Ste 120, Coppell, TX 75019 Phone: 469-619-7192

Dr. Bina Sharma, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 722 S Denton Tap Rd Ste 190, Coppell, TX 75019 Phone: 972-393-1200    Fax: 972-393-1234

Divya P Thomas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 922 Village Pkwy, Coppell, TX 75019 Phone: 408-799-2756    Fax: 617-492-2002

News Archive

Suprachiasmatic nucleus brain tissue sheds light on jet lag

New research led by a University of Washington biologist demonstrates that there are at least two circadian clocks in the mammal brain, one that sticks strictly to an internal schedule and another that can be altered by external influences such as light and dark.

Kessler Foundation researcher confirms link between sleep disturbances and MS-related fatigue

Kessler Foundation's Lauren Strober, PhD, explores the association of secondary fatigue and sleep disturbances in multiple sclerosis (MS). "Fatigue in multiple sclerosis: a look at the role of poor sleep" was published in Frontiers in Neurology.

Strong social support may reduce cardiovascular disease risk in postmenopausal women

Having good friends can save your life, as a study based on data from the Women's Health Initiative demonstrates how strong social support may reduce the risk of death from cardiovascular disease in postmenopausal women.

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

Read more Medical News

› Verified 8 days ago